A Study Assessing HMB-002 in Participants With Von Willebrand Disease
for Von Willebrand Disease (VWD)
Sites in Los Angeles +12 more locations
Sponsor: Hemab ApS
Sex: All·Age: 16 - 69
Code: NCT06754852·Phase 1, Phase 2·Recruiting·Listed Jan 2025
Paid Clinical Trials in California
California has 6,346 paid clinical trials enrolling now across cities including Los Angeles, San Francisco and San Diego. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Research sites in California include Stanford Medicine, UCLA Health and UCSF, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
5,270 clinical trials
Get a weekly email when new trials open in Los Angeles, CA.
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy
for Multiple System Atrophy
Sites in Los Angeles, La Jolla +13 more locations
Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Sex: All·Age: 30 - 75
Code: NCT06568237·Phase 2·Recruiting·Listed Aug 2024
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
for Focal Segmental Glomerulosclerosis
Drug: Brivekimig
Sites in San Francisco, Orange +14 more locations
Sponsor: Sanofi
Sex: All·Age: 16 - 75
Code: NCT06500702·Phase 2·Recruiting·Listed Jul 2024
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
for Immune Thrombocytopenia
Sites in Los Angeles, Clovis +10 more locations
Sponsor: Sanofi
Sex: All·Age: 18+
Code: NCT07007962·Phase 3·Recruiting·Listed Jun 2025
ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
for HR+/HER2- Breast Cancer
Sites in Los Angeles +15 more locations
Sponsor: Avenzo Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06998407·Phase 1, Phase 2·Recruiting·Listed May 2025
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
for Metastatic Cancer
Drug: Apalutamide
Sites in Los Angeles +11 more locations
Sponsor: Sun Pharmaceutical Industries Limited
Sex: Male·Age: 18+
Code: NCT05422911·Phase 2·Recruiting·Listed Jun 2022
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
for Acute Respiratory Distress Syndrome
Sites in Los Angeles +13 more locations
Sponsor: BioAegis Therapeutics Inc.
Sex: All·Age: 18+
Code: NCT05947955·Phase 2·Recruiting·Listed Jul 2023
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
for Adult Acute Myeloid Leukemia
Sites in Los Angeles, Duarte +11 more locations
Sponsor: Priothera SAS
Sex: All·Age: 18 - 75
Code: NCT05429632·Phase 3·Recruiting·Listed Jun 2022
SPYRAL GEMINI Pilot Study
for Hypertension
Sites in Stanford +11 more locations
Sponsor: Medtronic Vascular
Sex: All·Age: 18 - 80
Code: NCT06907147·Recruiting·Listed Apr 2025
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
for Idiopathic Hypersomnia
Sites in Redwood City, Santa Ana +11 more locations
Sponsor: Takeda
Sex: All·Age: 18 - 70
Code: NCT06812078·Phase 2·Recruiting·Listed Feb 2025
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
for Primary Membranous Nephropathy
Sites in Los Angeles, Tarzana +17 more locations
Sponsor: Cerium Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT05696613·Phase 3·Recruiting·Listed Jan 2023
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
for Gastric Adenocarcinoma
Sites in Orange +9 more locations
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All·Age: 18+
Code: NCT05365581·Phase 1·Recruiting·Listed May 2022
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
for Metastatic Castration-resistant Prostate Cancer
Sites in San Francisco +12 more locations
Sponsor: K36 Therapeutics, Inc.
Sex: Male·Age: 18+
Code: NCT07103018·Phase 1·Recruiting·Listed Aug 2025
A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection
for Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
Sites in Sacramento +11 more locations
Sponsor: Innoviva Specialty Therapeutics
Sex: All·Age: 18+
Code: NCT06746883·Recruiting·Listed Dec 2024
Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth in/Near Infected Bone Cavities
for Periprosthetic Joint Infections
Sites in Los Angeles +12 more locations
Sponsor: Elute, Inc.
Sex: All·Age: 22+·Accepts healthy volunteers
Code: NCT05361941·Recruiting·Listed May 2022
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
for Advanced Solid Tumors
Sites in Los Angeles, San Francisco +12 more locations
Sponsor: ModernaTX, Inc.
Sex: All·Age: 12+
Code: NCT05533697·Phase 1, Phase 2·Recruiting·Listed Sep 2022
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
for Solid Tumor, Adult
Sites in Los Angeles, La Jolla +10 more locations
Sponsor: A2 Biotherapeutics Inc.
Sex: All·Age: 18+
Code: NCT06051695·Phase 1, Phase 2·Recruiting·Listed Sep 2023
A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
for Extensive Stage Small Cell Lung Cancer
Drug: Tarlatamab
Sites in Los Angeles +12 more locations
Sponsor: Amgen
Sex: All·Age: 18 - 90
Code: NCT07037758·Phase 1·Recruiting·Listed Jun 2025
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
for Breast Cancer
Sites in Los Angeles, Duarte +20 more locations
Sponsor: Celcuity Inc
Sex: All·Age: 18+
Code: NCT06757634·Phase 3·Recruiting·Listed Jan 2025
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
for Benign Prostatic Hyperplasia
Sites in Los Angeles, Beverly Hills +17 more locations
Sponsor: Rivermark Medical
Sex: Male·Age: 45+
Code: NCT06849258·Recruiting·Listed Feb 2025
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
for Solid Tumor, Adult
Sites in Los Angeles, San Francisco +17 more locations
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Sex: All·Age: 18+
Code: NCT06625775·Phase 1·Recruiting·Listed Oct 2024
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
for Non-small Cell Lung Cancer (NSCLC)
Sites in Sacramento +16 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT06040541·Phase 1·Recruiting·Listed Sep 2023
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
for Unresectable Melanoma
Drug: IOV-4001
Sites in Los Angeles +9 more locations
Sponsor: Iovance Biotherapeutics, Inc.
Sex: All·Age: 18 - 70
Code: NCT05361174·Phase 1, Phase 2·Recruiting·Listed May 2022
A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
for GIST
Sites in Los Angeles +10 more locations
Sponsor: Deciphera Pharmaceuticals, LLC
Sex: All·Age: 18+
Code: NCT05957367·Phase 1, Phase 2·Recruiting·Listed Jul 2023
An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)
for Guillain-Barre Syndrome
Sites in Orange, Carlsbad +10 more locations
Sponsor: Annexon, Inc.
Sex: All·Age: 12 - 85
Code: NCT07020819·Phase 3·Recruiting·Listed Jun 2025
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
for Urothelial Carcinoma
Sites in San Francisco, Orange +7 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT05562830·Phase 1, Phase 2·Recruiting·Listed Oct 2022
Cephea Early Feasibility Study
for Mitral Regurgitation
Sites in Los Angeles, Sacramento +18 more locations
Sponsor: Abbott Medical Devices
Sex: All·Age: 18+
Code: NCT05061004·Recruiting·Listed Sep 2021
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
for Cholangiocarcinoma
Drug: Trametinib
Sites in Los Angeles +7 more locations
Sponsor: Genfit
Sex: All·Age: 18+
Code: NCT05874414·Phase 1, Phase 2·Recruiting·Listed May 2023
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
for Coagulation Disorder
Sites in Sacramento +12 more locations
Sponsor: Takeda
Sex: All·Age: 18+
Code: NCT05156983·Phase 3·Recruiting·Listed Dec 2021
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
for Pruritus
Drug: Dupilumab
Sites in La Jolla +16 more locations
Sponsor: Sanofi
Sex: All·Age: 18 - 90
Code: NCT05263206·Phase 3·Recruiting·Listed Mar 2022
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
for Multiple Myeloma
Drug: Linvoseltamab
Sites in La Jolla +12 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18+
Code: NCT05137054·Phase 1·Recruiting·Listed Nov 2021
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
for Chronic Lymphocytic Leukemia
Sites in Palo Alto, Duarte +19 more locations
Sponsor: Loxo Oncology, Inc.
Sex: All·Age: 18+
Code: NCT06588478·Phase 2·Recruiting·Listed Sep 2024
A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
for Lipidemia
Drug: Obicetrapib
Sites in La Jolla +19 more locations
Sponsor: NewAmsterdam Pharma
Sex: All·Age: 18+
Code: NCT07219602·Phase 3·Recruiting·Listed Oct 2025
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
for Schizophrenia
Sites in San Diego, Orange +20 more locations
Sponsor: Neurocrine Biosciences
Sex: All·Age: 18+
Code: NCT07105111·Phase 4·Recruiting·Listed Aug 2025
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
for Crohn's Disease
Drug: Risankizumab
Sites in Oakland +10 more locations
Sponsor: AbbVie
Sex: All·Age: 2 - 17
Code: NCT05995353·Phase 3·Recruiting·Listed Aug 2023
Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
for Cerebral Vasospasm
Sites in Walnut Creek, Burbank +14 more locations
Sponsor: Vesalio
Sex: All·Age: 22+
Code: NCT06893588·Recruiting·Listed Mar 2025
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
for Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)
Sites in Los Angeles, San Francisco +14 more locations
Sponsor: Fate Therapeutics
Sex: All·Age: 12 - 70
Code: NCT06308978·Phase 1·Recruiting·Listed Mar 2024
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
for Non-Small Cell Lung Cancer
Sites in Los Angeles, San Francisco +14 more locations
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Sex: All·Age: 18+
Code: NCT06917079·Phase 1·Recruiting·Listed Apr 2025
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
for Non-small Cell Lung Cancer (NSCLC)
Sites in Orange, Santa Monica +19 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT05379985·Phase 1, Phase 2·Recruiting·Listed May 2022
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
for Solid Tumor
Sites in Santa Monica +10 more locations
Sponsor: Astellas Pharma Inc
Sex: All·Age: 18+
Code: NCT07094204·Phase 1·Recruiting·Listed Jul 2025